Vitiligo in children: A review of classification, hypotheses of pathogenesis and treatment;Vitiligo em crianças: Uma revisão de classificaçã o, hipóteses sobre patogênese e tratamento

Anais Brasileiros de Dermatologia

Volumn 80, Issue 6, 2005, Pages 631-636

  Bellet, Jane S ^b   Prose, Neil S ^a  

^a Department of Medicine ^*

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Epidermis transplantation; PUVA therapy; Vitiligo

Indexed keywords

CORTICOSTEROID; COSMETIC; PIMECROLIMUS; PSORALEN; TACROLIMUS;

ATROPHY; AUTOIMMUNITY; BLEACHING; CELL LOSS; CELL TRANSPLANTATION; CHILDHOOD DISEASE; CLINICAL TRIAL; DEPIGMENTATION; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; META ANALYSIS; PATHOGENESIS; PHOTOTHERAPY; PUVA; REVIEW; SKIN TRANSPLANTATION; SYSTEMATIC REVIEW; ULTRAVIOLET B RADIATION; VITILIGO;

EID: 33846673313     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/s0365-05962005000700009     Document Type: Review

References (34)

1. Zhang XJ, Liu JB, Gui JP, Li M, Xiong QG, Wu HB L, et al. Characteristics of genetic epidemiology and genetic models for vitiligo. J Am Acad Dermatol. 2004;51:383-90.
2. Schwartz RA, Janniger CK. Vitiligo. Cutis. 1997;60:239-44.
3. Hann SK, Chang JH, Lee HS, Kim SM. The classification of segmental vitiligo on the face. Yonsei Med J. 2000;41:209-12.
4. Halder RM, Grimes PE, Cowan CA, Enterline JA, Chakrabarti SG, Kenney JA. Childhood vitiligo. J Am Acad Dermatol. 1987;16:948-54.
5. Jaisankar TJ, Baruah MC, Garg BR. Vitiligo in children. Int J Dermatol. 1992;31(9):621-3.
6. Taieb A. Intrinsic and extrinsic pathomechanisms in vitiligo. Pigment Cell Res. 2000;13:41-7.
7. Mattoo SK, Handa S, Kaur I, Gupta N, Malhotra R. Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol. 2002;16:573-8.
8. Hann SK, Lee HJ. Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol. 1996;35:671-4.
9. Crowson AN, Carlson-Sweet K, Barnhill RL. Disorders of Pigmentation. In: Barnhill RL, Crowson RL, editors. Textbook of dermatopathology. 2nd ed. New York: McGraw-Hill, 2004. p. 359-79.
10. Lee DJ, Modlin RL. Breaking tolerance-another piece added to the vitiligo puzzle. J Invest Dermatol. 2004;124:xii-xv.
11. Wang X, Erf GF. Melanocyte-specific cell mediated immune response in vitiliginous Smyth line chickens. J Autoimmun. 2003;21:149-60.
12. Iacovelli P, Sinagra JLK, Vidolin AP, Marenda S, Capitanio B, Leone G, et al. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology. 2005;210:26-30.
13. Kakourou T, Kanaka-Gantenbein C, Papadopoulou A, Kaloumenou E, Chrousos GP Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo. J Am Acad Dermatol. 2005;53:220-3.
14. Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR, et al. Early disease onset and increased risk of other autoimmune disease in familial generalized vitiligo. Pigment Cell Res. 2005;18:300-5.
15. Roberts A, Kaye LC, Memon A, Parslew R, Kaye SB. Unilateral poliosis of the eyelashes in children associated with vitiligo. J AAPOS. 2005;9:295-6.
16. Ando I, Chi HI, Nakagawa H, Otsuka F. Difference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type. Br J Dermatol. 1993;129:408-10.
17. Njoo MD, Westerhof W, Bos JD, Bossuyt PM. The development of guidelines for the treatment of vitiligo. Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolota-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology. Arch Dermatol. 1999;135:1514-21.
18. Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PMM. Nonsurgical repigmentation therapies in vitiligo: meta-analysis of the literature. Arch Dermatol. 1998;134:1532-40.
19. Grimes PE, Soriano T, Dytoc MT. Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol. 2002;47:789-91.
20. Lepe V, Moncada B, Castandeo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clo betasol for the treatment of childhood vitiligo. Arch Dermatol. 2003;139:581-5.
21. Plettenberg H, Assmann T, Ruzicka T. Childhood vitiligo and tacrolimus. Arch Dermatol. 2003;139:651-4.
22. Caelles IP, Pinto PH, Casado LDEL, Laguna RDL. Focal hypertrichosis during topical tacrolimus therapy for childhood vitiligo. Pediatr Dermatol. 2005;22:86-7.
23. Roelandts R. Photo (chemo)therapy for vitiligo. Photodermatol Photoimmunol Photomed. 2003;19:1-4.
24. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol. 1997;133:1525-8.
25. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol. 2000;42:245-53.
26. Kanwar AJ, Dogra AJ. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin Exp Dermatol. 2005;30:332-6.
27. Kanwar AJ, Dogra S, Parsad D, Kumar B. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy. Int J Dermatol. 2005;44:57.
28. Brazelli V, Prestinari F, Castello M, Bellani E, Roveda E, Barbagallo T, et al. Useful treatment of vitiligo in 10 children with UV-B Narrowband (311 nm). Pediatr Dermatol. 2005;22:257-61.
29. Menchini G, Tsoureli-Nikita E, Hercogova J. Narrow-band UVB micro-phototherapy: a new treatment for vitiligo. J Eur Acad Dermatol Venereol. 2003;17:171-7.
30. Leone G, Iacovelli P, Paro Vidolin A, Picardo M. Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study. J Eur Acad Dermatol Venereol. 2003;17:531-7.
31. Gupta S, Kumar B. Epidermal grafting in vitiligo: influence of age, site of lesion, and type of disease on outcome. J Am Acad Dermatol. 2003;49:99-104.
32. Khandpur S, Sharma VK, Manchanda Y. Comparison of mini-punch grafting versus split-skin grafting in chronic stable vitiligo. Dermatol Surg. 2005;31:436-41.
33. Mulekar SV Melanocyte-keratinocyte cell transplantation for stable vitiligo. Int J Dermatol. 2003;42:132-6.
34. Ongenae K, Dierckzsens L, Brochez L, Van Geel N, Naeyaert JM. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology. 2005;210:279-85.